Fig. 3.
The association between progression-free survival of first-line epidermal growth factor receptor-tyrosine kinase inhibitor and T790M mutation status of rebiopsy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.